Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bacterial 50S ribosomal subunit – 23S rRNA nascent peptide exit tunnel (NPET) is a critical structural channel within the large ribosomal subunit through which newly synthesized polypeptide chains pass to reach the exterior of the ribosome (Kannan & Mankin, 2011). Spanning approximately 100 Å in length and 10–20 Å in width, the tunnel is primarily composed of 23S ribosomal RNA (rRNA) and is constricted by the loops of ribosomal proteins uL4 and uL22 (Vázquez-Laslop & Mankin, 2018). Beyond its role as a passive conduit, the NPET actively participates in translation regulation and co-translational protein folding by sensing specific nascent peptide sequences (Kannan & Mankin, 2012). It serves as the primary therapeutic target for several major classes of antibiotics, including macrolides, lincosamides, and streptogramins, which bind within the tunnel to physically obstruct the passage of the growing peptide (Arenz & Wilson, 2016). This obstruction leads to the cessation of protein synthesis and subsequent inhibition of bacterial growth, making it a cornerstone of antimicrobial therapy for various infections (Patsnap, 2024). Resistance to these drugs often arises through modifications of the tunnel's components, such as the methylation of the A2058 residue in the 23S rRNA or mutations in the uL4 and uL22 proteins (Vázquez-Laslop & Mankin, 2018). Furthermore, the structural similarity between bacterial and human mitochondrial ribosomes can lead to off-target effects, presenting a significant challenge in drug design (Biomolecules, 2024). Understanding the complex interactions within the NPET is essential for developing next-generation antibiotics that can bypass existing resistance mechanisms (Kannan & Mankin, 2011).
Inhibition of protein synthesis by binding to the 23S rRNA within the upper chamber of the exit tunnel, physically obstructing the passage of the nascent peptide chain and inducing premature dissociation of peptidyl-tRNA from the ribosome.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit – 23S rRNA nascent peptide exit tunnel (NPET).